Loading…

Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer – A TEAM study analysis

Abstract Background Multiple studies suggest better efficacy of chemotherapy in invasive ductal breast carcinomas (IDC) than invasive lobular breast carcinomas (ILC). However, data on efficacy of adjuvant endocrine therapy regimens and histological subtypes are sparse. This study assessed endocrine...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2013-01, Vol.49 (2), p.297-304
Main Authors: van de Water, Willemien, Fontein, Duveken B.Y, van Nes, Johanna G.H, Bartlett, John M.S, Hille, Elysée T.M, Putter, Hein, Robson, Tammy, Liefers, Gerrit-Jan, Roumen, Rudi M.H, Seynaeve, Caroline, Dirix, Luc Y, Paridaens, Robert, Kranenbarg, Elma Meershoek-Klein, Nortier, Johan W.R, van de Velde, Cornelis J.H
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Multiple studies suggest better efficacy of chemotherapy in invasive ductal breast carcinomas (IDC) than invasive lobular breast carcinomas (ILC). However, data on efficacy of adjuvant endocrine therapy regimens and histological subtypes are sparse. This study assessed endocrine therapy efficacy in IDC and ILC. The influence of semi-quantitative oestrogen receptor (ER) expression by Allred score was also investigated. Methods Dutch and Belgian patients enrolled in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial were randomized to exemestane (25 mg daily) alone or following tamoxifen (20 mg daily) for 5 years. Inclusion was restricted to IDC and ILC patients. Histological subtype was assessed locally; ER expression was centrally reviewed according to Allred score (ER-poor (
ISSN:0959-8049
1879-0852
DOI:10.1016/j.ejca.2012.07.026